A new “Comparative Effectiveness” assessment strategy using the THIN database: comparison of the cardiac complications of pioglitazone and rosiglitazone

Jan-13

AUTHORS : Dr Dawei Xie, Department of Biostatics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, 423 Guardian Drive, 227 Blockley Hall, Philadelphia, Pa 19104 – Email: dxie@upenn.edu – Profile: https://www.dbei.med.upenn.edu/bio/dawei-xie-phd – Prof Richard Tannen, University of Pennsylvania School of Medicine, Medicine, Philadelphia, passed away in 2020

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 22(1):86-97

DOI : 10.1002/pds.3360

A new “Comparative Effectiveness” assessment strategy using the THIN database: comparison of the cardiac complications of pioglitazone and rosiglitazone

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study